Product NDC: | 21695-949 |
Proprietary Name: | OPANA ER |
Non Proprietary Name: | Oxymorphone Hydrochloride |
Active Ingredient(s): | 10 mg/1 & nbsp; Oxymorphone Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 21695-949 |
Labeler Name: | Rebel Distributors Corp |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021610 |
Marketing Category: | NDA |
Start Marketing Date: | 20060622 |
Package NDC: | 21695-949-60 |
Package Description: | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (21695-949-60) |
NDC Code | 21695-949-60 |
Proprietary Name | OPANA ER |
Package Description | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (21695-949-60) |
Product NDC | 21695-949 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Oxymorphone Hydrochloride |
Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20060622 |
Marketing Category Name | NDA |
Labeler Name | Rebel Distributors Corp |
Substance Name | OXYMORPHONE HYDROCHLORIDE |
Strength Number | 10 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |